Literature DB >> 15621040

Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity.

Anne Royer1, Sophie Demolombe, Aziza El Harchi, Khaï Le Quang, Julien Piron, Gilles Toumaniantz, David Mazurais, Chloé Bellocq, Gilles Lande, Cécile Terrenoire, Howard K Motoike, Jean-Christophe Chevallier, Gildas Loussouarn, Colleen E Clancy, Denis Escande, Flavien Charpentier.   

Abstract

OBJECTIVE: The K(+) channel encoded by the human ether-a-go-go-related gene (HERG) is crucial for repolarization in the human heart. In order to investigate the impact of HERG current (I(Kr)) on the incidence of cardiac arrhythmias, we generated a transgenic mouse expressing HERG specifically in the heart. METHODS AND
RESULTS: ECG recordings at baseline showed no obvious difference between transgenic and wild-type (WT) mice with the exception of the T wave, which was more negative in transgenic mice than in WT mice. E4031 (20 mg/kg) prolonged the QTc interval and flattened the T wave in transgenic mice, but not in WT mice. Injection of BaCl(2) (25 mg/kg) induced short runs of ventricular tachycardia in 9/10 WT mice, but not in transgenic animals. Atrial pacing reproducibly induced atrial tachyarrhythmias in 11/15 WT mice. In contrast, atrial arrhythmia was inducible in only 2/11 transgenic mice. When pretreated with dofetilide (10 mg/kg), transgenic mice were as sensitive to experimental arrhythmias as WT mice. Microelectrode studies showed that atrial action potentials have a steeper slope of duration-rate adaptation in WT than in transgenic mice. Transgenic mice were also characterized by a post-repolarization refractoriness, which could result from the substantial amount of I(Kr) subsisting after repolarization as assessed with action potential-clamp experiments and simulations with a model of the transgenic mouse action potential.
CONCLUSION: HERG expression in the mouse heart can protect against experimental induction of arrhythmias. This is the first report of such a protective effect of HERG in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15621040     DOI: 10.1016/j.cardiores.2004.09.030

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

1.  Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes.

Authors:  Malin K B Jonsson; Qing-Dong Wang; Bruno Becker
Journal:  Assay Drug Dev Technol       Date:  2011-11-15       Impact factor: 1.738

Review 2.  Interpreting genetic effects through models of cardiac electromechanics.

Authors:  S A Niederer; S Land; S W Omholt; N P Smith
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-10-05       Impact factor: 4.733

3.  Transmural heterogeneity of repolarization and Ca2+ handling in a model of mouse ventricular tissue.

Authors:  Vladimir E Bondarenko; Randall L Rasmusson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-06-04       Impact factor: 4.733

4.  Arrhythmia phenotype in mouse models of human long QT.

Authors:  Guy Salama; Linda Baker; Robert Wolk; Jacques Barhanin; Barry London
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

5.  Allocryptopine and benzyltetrahydropalmatine block hERG potassium channels expressed in HEK293 cells.

Authors:  Kun Lin; Yu-qi Liu; Bin Xu; Jin-liao Gao; Yi-cheng Fu; Yu Chen; Qiao Xue; Yang Li
Journal:  Acta Pharmacol Sin       Date:  2013-03-25       Impact factor: 6.150

6.  Characterization of Erg K+ channels in alpha- and beta-cells of mouse and human islets.

Authors:  Alexandre B Hardy; Jocelyn E Manning Fox; Pejman Raeisi Giglou; Nadeeja Wijesekara; Alpana Bhattacharjee; Sobia Sultan; Armen V Gyulkhandanyan; Herbert Y Gaisano; Patrick E MacDonald; Michael B Wheeler
Journal:  J Biol Chem       Date:  2009-08-18       Impact factor: 5.157

7.  Initial segment Kv2.2 channels mediate a slow delayed rectifier and maintain high frequency action potential firing in medial nucleus of the trapezoid body neurons.

Authors:  Jamie Johnston; Sarah J Griffin; Claire Baker; Anna Skrzypiec; Tatanya Chernova; Ian D Forsythe
Journal:  J Physiol       Date:  2008-05-29       Impact factor: 5.182

8.  Electrophysiological characterization of the hERG R56Q LQTS variant and targeted rescue by the activator RPR260243.

Authors:  Jacob M Kemp; Dominic G Whittaker; Ravichandra Venkateshappa; ZhaoKai Pang; Raj Johal; Valentine Sergeev; Glen F Tibbits; Gary R Mirams; Thomas W Claydon
Journal:  J Gen Physiol       Date:  2021-08-16       Impact factor: 4.086

9.  Predicting drug-induced changes in QT interval and arrhythmias: QT-shortening drugs point to gaps in the ICHS7B Guidelines.

Authors:  H R Lu; E Vlaminckx; A N Hermans; J Rohrbacher; K Van Ammel; R Towart; M Pugsley; D J Gallacher
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.